Are corticosteroids effective for prevention of scar formation after second-degree skin burn?

被引:12
作者
Taheri, Arash [1 ]
Mansoori, Parisa [2 ]
Al-Dabagh, Amir [1 ]
Feldman, Steven R. [1 ,2 ,3 ]
机构
[1] Wake Forest Sch Med, Dept Dermatol, Ctr Dermatol Res, Winston Salem, NC 27104 USA
[2] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC 27104 USA
[3] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27104 USA
关键词
glucocorticoid; inflammation; keloid; steroid; ulcer; POSTOPERATIVE STEROID INJECTIONS; HYPERTROPHIC SCARS; TRIAMCINOLONE ACETONIDE; KELOIDS; MANAGEMENT; EXCISION; PATHOPHYSIOLOGY; RECURRENCE; EXPRESSION; THERAPY;
D O I
10.3109/09546634.2013.806768
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Superficial second-degree skin burns only need re-epithelialization to heal without a scar. After re-epithelialization, inflammation in the dermis contributes to changes in skin architecture and scarring. Suppression of inflammation and fibroblast activation immediately after re-epithelialization may prevent scar formation. Corticosteroids are the mainstay of treatment for keloids and hypertrophic scars. Objective: To assess the available data on use of corticosteroids for prevention of scars. Methods: A review of literature was performed seeking clinical trials using corticosteroids for prevention of scars. Results: Corticosteroids have been used to prevent recurrence after keloid or hypertrophic scar excision with variable success. We did not find any report involving the clinical use of corticosteroids for the prevention of scar formation in other settings, including after skin burns. Conclusion: Theoretically, topical corticosteroids can suppress inflammation and fibroblast activation after skin burn, decreasing the incidence of scar formation. However, there is no study evaluating this hypothesis.
引用
收藏
页码:360 / 362
页数:3
相关论文
共 23 条
[1]  
American Burn Association, 2012, BURN INC TREATM US 2
[2]  
ASHLEY FL, 1973, CALIF MED, V119, P65
[3]   Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections [J].
Berman, B ;
Flores, F .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (05) :755-757
[4]   Wound healing: An overview [J].
Broughton, G ;
Janis, JE ;
Attinger, CE .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (07) :294S-294S
[5]   Keloids and hypertrophic scars: Results with intra-operative and serial postoperative corticosteroid injection therapy [J].
Chowdri, NA ;
Mattoo, MMA ;
Darzi, MA .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1999, 65 (09) :655-659
[6]   Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice [J].
Fassler, R ;
Sasaki, T ;
Timpl, R ;
Chu, ML ;
Werner, S .
EXPERIMENTAL CELL RESEARCH, 1996, 222 (01) :111-116
[7]   Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies [J].
Gauglitz, Gerd G. ;
Korting, Hans C. ;
Pavicic, Tatiana ;
Ruzicka, Thomas ;
Jeschke, Marc G. .
MOLECULAR MEDICINE, 2011, 17 (1-2) :113-125
[8]   A New Uniform Protocol of Combined Corticosteroid Injections and Ointment Application Reduces Recurrence Rates After Surgical Keloid/Hypertrophic Scar Excision [J].
Hayashi, Toshihiko ;
Furukawa, Hiroshi ;
Oyama, Akihiko ;
Funayama, Emi ;
Saito, Akira ;
Murao, Naoki ;
Yamamoto, Yuhei .
DERMATOLOGIC SURGERY, 2012, 38 (06) :893-897
[9]   Major suppression of pro-alpha 1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide [J].
Kauh, YC ;
Rouda, S ;
Mondragon, G ;
Tokarek, R ;
diLeonardo, M ;
Tuan, RS ;
Tan, EML .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (04) :586-589
[10]   Molecular pathology of wound healing [J].
Kondo, Toshikazu ;
Ishida, Yuko .
FORENSIC SCIENCE INTERNATIONAL, 2010, 203 (1-3) :93-98